tiprankstipranks
Day One Biopharmaceuticals, Inc. (DAWN)
:DAWN
US Market

Day One Biopharmaceuticals (DAWN) Income Statement

Compare
320 Followers

Day One Biopharmaceuticals Income Statement

Last quarter (Q3 2024), Day One Biopharmaceuticals's total revenue was $93.76M, an increase of Infinity% from the same quarter last year. In Q3, Day One Biopharmaceuticals's net income was $37.04M. See Day One Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -383.00K$ -531.00K$ -199.00K$ -155.00K$ 0.00
Operating Expenses
$ 206.06M$ 146.91M$ 72.74M$ 13.78M$ 14.90M
Depreciation and Amortization
$ 383.00K$ 531.00K$ 199.00K$ 155.00K$ 14.90M
EBITDA
$ -206.06M$ -141.65M$ -72.56M$ -43.66M$ -2.00K
Operating Income
$ -206.06M$ -146.91M$ -72.74M$ -13.78M$ -14.90M
Other Income/Expenses
$ 17.15M$ 4.73M$ -11.00K$ -30.06M$ -2.08M
Pretax Income
$ -188.92M$ -142.18M$ -72.75M$ -43.84M$ -16.98M
Net Income
$ -188.92M$ -132.18M$ -70.44M$ -40.51M$ -14.71M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.37$ -2.02$ -1.14$ -0.65$ -0.24
Diluted EPS
$ -2.37$ -2.02$ -1.14$ -0.65$ -0.24
Weighted Average Shares Outstanding
79.77M 65.47M 61.95M 61.93M 61.93M
Weighted Average Shares Outstanding (Diluted)
79.77M 65.47M 61.95M 61.93M 61.93M
Currency in USD

Day One Biopharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis